Advertisement
Erratum| Volume 4, ISSUE 2, 100458, February 2023

Erratum

    Open AccessPublished:January 12, 2023DOI:https://doi.org/10.1016/j.jtocrr.2022.100458
        In the published article titled “Creation of an integrated clinical trial database and data sharing for conducting new research by the Japan Lung Cancer Society,” JTO Clin Res Rep. 2022;3:100317, the authors have discovered some errors in their paper:
        Specifically, regarding the results of the PFS and OS analysis. In the paper, the median PFS 9.6 months (95%CI 10.5-22.0), 2, 5, 10 year, PFS rates 23.6%, 14.0%, 9.4%, median OS 26.0 months (95%CI 24.5-27.9), 2, 5, 10 year, OS rates 53.7%, 24.8%, 15.2% were not correct. The data should have been stated as, the median PFS 9.5 months (95%CI 8.9-10.0), 2, 5, 10 year PFS rates, 22.4%, 13.0%, 9.1%, median OS 24.6 months (95%CI 22.9-26.3), 2, 5, 10 year OS rates 51.1%, 22.5%, 13.8%. The authors apologize for their lack of confirmation.
        Address for correspondence: Yuichi Ozawa, MD, PhD, E-mail: [email protected]

        Linked Article